Famitinib enhances the antitumor effect of radioimmunotherapy in murine lung cancer
Abstract Background Combining antiangiogenic therapy with radioimmunotherapy is believed to further improve antitumor efficacy, but there is still a lack of evidence to support this. This study aimed to investigate the role of the tumor vascular‐targeted agent famitinib with a combination of radioth...
Guardat en:
| Autors principals: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wiley
2022-12-01
|
| Col·lecció: | Thoracic Cancer |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1111/1759-7714.14689 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|